featured
Improved Overall Survival With Ribociclib Plus Fulvestrant in Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Overall Survival With Ribociclib Plus Fulvestrant in Advanced Breast Cancer
N. Engl. J. Med 2019 Dec 11;[EPub Ahead of Print], DJ Slamon, P Neven, S Chia, PA Fasching, M De Laurentiis, SA Im, K Petrakova, G Val Bianchi, FJ Esteva, M Martín, A Nusch, GS Sonke, L De la Cruz-Merino, JT Beck, X Pivot, M Sondhi, Y Wang, A Chakravartty, K Rodriguez-Lorenc, T Taran, G JerusalemFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.